XNCR

NASD Xencor, Inc.
Oct 21, 2026 · 6:39 PM ET LAST TRADE Market Closed

$25.48 ↑ +0.32 (+1.27%) Trading Up from the previous close of $25.16, $0.02 below the day’s high of $25.50

YTD change
+66.43%
vs 20-day SMA
+4.55%
vs 200-day SMA
+55.33%

Price ranges

Previous day
$23.25 $25.01
open $23.25 close $24.94
+$1.69 (+7.27%)
Today
$24.42 $25.50
open $25.00 now $25.48
+$0.48 (+1.92%)
Past week
$21.97 $25.01
from $23.52 now $25.48
+$1.96 (+8.33%)
Past month
$21.97 $26.35
from $25.16 now $25.48
+$0.32 (+1.27%)
This year
$10.38 $30.61
from $15.31 now $25.48
+$10.17 (+66.43%)

Price & Performance

+12.33 (+97.78%) / 6M

$8.90$16.20$23.51$30.81Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 56.3% away from all-time highs of $58.35
  • XNCR is up 66% since the beginning of the year
  • XNCR is up 76% over the past 12 months
  • XNCR is up 1% over the past 1 month
  • 23% of all XNCR investors are betting against XNCR

XNCR reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +71.9%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.29
Earnings momentum +24.5% Quarterly EPS growth
Quarterly change +24.5%

Valuation

P/E ratio N/A
Enterprise value $1.6B
Beta 1.12

Balance sheet & scale

IncomeN/A
Revenue$105.0M
Cash$456.5M
Debt$170.1K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.9B

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Pasadena, CA.

Competitor comparison

TickerCompany PriceChange
REGN Regeneron Pharmaceuticals, Inc. $807.48 +3.25%
IQV IQVIA Holdings Inc $267.85 +0.74%
CRL Charles River Laboratories International, Inc. $315.45 +5.14%
IT Gartner, Inc. $219.64 +5.74%
ICLR ICON Plc $174.19 +3.60%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.